These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22340901)

  • 21. Acceptance of yellow fever vaccine in the older traveller: a cohort study.
    Ferrara P; Masuet-Aumatell C; Ramon-Torrell JM
    Acta Biomed; 2021 Sep; 92(4):e2021098. PubMed ID: 34487067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccine administration decision making: the case of yellow fever vaccine.
    Lown BA; Chen LH; Wilson ME; Sisson E; Gershman M; Yanni E; Jentes ES; Hochberg NS; Hamer DH; Barnett ED
    Clin Infect Dis; 2012 Sep; 55(6):837-43. PubMed ID: 22670048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late vaccination against yellow fever of travelers visiting endemic countries.
    Krief I; Goldblatt JG; Paz A; Potasman I
    Travel Med Infect Dis; 2006 Mar; 4(2):94-8. PubMed ID: 16887731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse event reports following yellow fever vaccination.
    Lindsey NP; Schroeder BA; Miller ER; Braun MM; Hinckley AF; Marano N; Slade BA; Barnett ED; Brunette GW; Horan K; Staples JE; Kozarsky PE; Hayes EB
    Vaccine; 2008 Nov; 26(48):6077-82. PubMed ID: 18809449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of the risks and benefits of yellow fever vaccination including some new analyses.
    Monath TP
    Expert Rev Vaccines; 2012 Apr; 11(4):427-48. PubMed ID: 22551029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccines and vaccination against yellow fever: WHO Position Paper, June 2013--recommendations.
    Who
    Vaccine; 2015 Jan; 33(1):76-7. PubMed ID: 24852721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of the yellow Fever vaccine: a retrospective study.
    Nordin JD; Parker ED; Vazquez-Benitez G; Kharbanda EO; Naleway A; Marcy SM; Molitor B; Kuckler L; Baggs J
    J Travel Med; 2013; 20(6):368-73. PubMed ID: 24118538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of yellow fever in persons traveling to the tropics.
    Monath TP; Cetron MS
    Clin Infect Dis; 2002 May; 34(10):1369-78. PubMed ID: 11981733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever.
    Jentes ES; Poumerol G; Gershman MD; Hill DR; Lemarchand J; Lewis RF; Staples JE; Tomori O; Wilder-Smith A; Monath TP;
    Lancet Infect Dis; 2011 Aug; 11(8):622-32. PubMed ID: 21798462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations].
    Yaméogo TM; Breugelmans JG; Kambou JL; Badolo O; Tiendrebéogo S; Traoré E; Avokey F; Yactayo S
    Med Trop (Mars); 2009 Aug; 69(4):320-1. PubMed ID: 19725376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Yellow fever vaccination centers: concurrent vaccinations and updates on mosquito biology.
    Arya SC; Agarwal N
    Travel Med Infect Dis; 2012 Sep; 10(5-6):257-8. PubMed ID: 22613468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yellow Fever in Travelers.
    Wilder-Smith A
    Curr Infect Dis Rep; 2019 Oct; 21(11):42. PubMed ID: 31673899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Yellow fever vaccination: update on rare and severe adverse effects].
    Receveur MC; Bruyand M; Pistone T; Malvy D
    Med Mal Infect; 2009 Apr; 39(4):234-41. PubMed ID: 19167852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transfusion-related transmission of yellow fever vaccine virus--California, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jan; 59(2):34-7. PubMed ID: 20094025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. To err is human: Clinical incident calls to a national travel health advice line.
    McCallum AD; Kanagarajah S; Ford L; Patel D
    Vaccine; 2019 Dec; 37(52):7535-7538. PubMed ID: 31611096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The quality of travel clinics in the Netherlands.
    Moerland W; Koeman SC; van den Hoek A; Warris-Versteegen AA; Inspector H; Overbosch D; Sonder GJ
    J Travel Med; 2006; 13(6):356-60. PubMed ID: 17107429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yellow Fever Vaccination of a Primary Vaccinee During Adalimumab Therapy.
    Nash ER; Brand M; Chalkias S
    J Travel Med; 2015; 22(4):279-81. PubMed ID: 25922988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enquiries to the United Kingdom National Travel Advice Line by healthcare professionals regarding immunocompromised travellers.
    Allen JE; Patel D
    J Travel Med; 2016 Mar; 23(3):. PubMed ID: 27021497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Yellow Fever Vaccine Administration at Global TravEpiNet (GTEN) Clinics during a Period of Limited Vaccine Availability in the United States, 2017-2018.
    Walker AT; Gershman MD; Rao SR; LaRocque RC; Ryan ET;
    Am J Trop Med Hyg; 2021 Jan; 104(3):1079-1084. PubMed ID: 33534766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yellow fever vaccination: how much is enough?
    Massad E; Coutinho FA; Burattini MN; Lopez LF; Struchiner CJ
    Vaccine; 2005 Jun; 23(30):3908-14. PubMed ID: 15917112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.